Advisor Group Holdings, Inc. Aeglea Bio Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.11 - $0.46 $550 - $2,300	5,000 New	5,000 $2,000
Q2 2022 Aug 10, 2022	BUY	$0.5 - $2.66 $235 - $1,250	470 New	470 $0
Q4 2020 Feb 10, 2021	SELL	$7.02 - $9.83 $5,510 - $7,716	-785 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$3.51 - $8.48 $2,755 - $6,656	785 New	785 $4,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.